Paper37258484
Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease.
Handra CM and 3 others. Front Biosci (Landmark Ed), 2023. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Silicosis: New Challenges from an Old Inflammatory and Fibrotic Disease. Papers, record 37258484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37258484
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Silicon Dioxide | Major topic |
| Silicosis | Major topic |
| Female | |
| Humans | |
| Male | |
| Fibrosis | |
| Inflammation | |
| Dust |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42613079 | Murine models of pulmonary fibrosis: mechanisms, limitations and translational insights. | Eur Respir Rev | 2026 | https://conductscience.org/library/papers/42613079 | PubMed |
| 42505552 | AhR as a Common Denominator in Immunity and Inflammation in Chronic Lung Diseases: Molecular and Clinical Insights. | Diseases | 2026 | https://conductscience.org/library/papers/42505552 | PubMed |
| 42158956 | Tools of the trade: leveraging 3D in vitro models to advance silicosis research. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42158956 | PubMed |
| 41959009 | Alveolar-Basal Intermediates Drive Pulmonary Fibrosis via Coordination of a Pro-Fibrotic Signaling Niche in Silicosis. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959009 | PubMed |
| 41939412 | Efficiency Comparison of Reduced Graphene Oxide (rGO) Composite-Incorporated Polyacrylonitrile Nanofibrous Filters for Respirable Crystalline Silica Dust and Coal Dust. | ACS Omega | 2026 | https://conductscience.org/library/papers/41939412 | PubMed |
| 41540455 | CPSF6-mediated alternative polyadenylation of RUNX1 to regulate silica-induced pulmonary fibrosis progression. | Respir Res | 2026 | https://conductscience.org/library/papers/41540455 | PubMed |
| 41492371 | Pathogenesis of various pulmonary diseases by tuning immune response: insight from host-microbial crosstalk. | Curr Res Microb Sci | 2026 | https://conductscience.org/library/papers/41492371 | PubMed |
| 41378210 | Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41378210 | PubMed |
| 41281466 | Diagnosing Pleural Effusion Caused by Silicosis in a Long-Term Quarry Worker: A Case Report. | Int Med Case Rep J | 2025 | https://conductscience.org/library/papers/41281466 | PubMed |
| 41069828 | Internal and external silica dust exposure threshold as an early screening index for silicosis: a cross-sectional study. | Front Public Health | 2025 | https://conductscience.org/library/papers/41069828 | PubMed |
| 40845047 | A combination of silica and cigarette smoke extract exacerbates lung fibrosis: Unveiling a harmful synergy. | PLoS One | 2025 | https://conductscience.org/library/papers/40845047 | PubMed |
| 40751157 | Serum Krebs von den Lungen-6 as a potential biomarker for early diagnosis of silicosis: a case-control study. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/40751157 | PubMed |
| 40684152 | Tetrandrine slows disease progression on high-resolution computed tomography and lung function decline in artificial stone-associated silicosis: a retrospective cohort study. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/40684152 | PubMed |
| 40683107 | Cell and tissue reprogramming: Unlocking a new era in medical drug discovery. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/40683107 | PubMed |
| 40547038 | Single-cell and spatial transcriptomics reveal a stress-induced EMT-like epithelial subset driving immune activation in silica-injured lung. | Front Immunol | 2025 | https://conductscience.org/library/papers/40547038 | PubMed |
| 40358809 | Role of macrophage ATP metabolism disorder in SiO2‑induced pulmonary fibrosis: a review. | Purinergic Signal | 2025 | https://conductscience.org/library/papers/40358809 | PubMed |
| 40083511 | Burden of silicosis based on the Global Burden of Disease Study 2021: trend analysis of incidence, mortality, and disability-adjusted life years, and projections for the next 30 years. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/40083511 | PubMed |
| 40027509 | Unveiling the threat of crystalline silica on the cardiovascular system. A comprehensive review of the current knowledge. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40027509 | PubMed |
| 39819422 | Prevalence and determinants of restrictive lung disorder among quarry workers at the Umuoghara quarry site, Ebonyi State, Nigeria: a cross-sectional study. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/39819422 | PubMed |
| 39694587 | Silicotuberculosis: a critical narrative review. | Eur Respir Rev | 2024 | https://conductscience.org/library/papers/39694587 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37258484
GET https://conductscience.org/api/papers/v1/37258484/cited_by?page=2